A new Schiff base compound 2-((benzylimino)-methyl)-naphthalen-1-ol (2BIMN1O) has been synthesized and characterized by ¹H NMR, ¹³C NMR, DEPT, FT-IR and mass spectroscopic techniques. The significantly low fluorescence yield of the compound has been rationalized in connection with photo-induced electron transfer (PET) from the imine receptor moiety to the naphthalene fluorophore unit. Subsequently, an evaluation of the transition metal ion-induced modification of the fluorophore–receptor communication reveals a promising prospect for the title compound to function as a fluorosensor for Cu²⁺ and Zn²⁺ ions selectively, through remarkable fluorescence enhancement. While perturbation of the PET process in 2BIMN1O has been argued to be the responsible mechanism behind the fluorescence enhancement, the selectivity for these two metal ions has been interpreted on the grounds of an appreciably strong binding interaction. Particularly notable aspects regarding the chemosensory activity of the compound are its ability to detect the aforesaid transition metal ions down to the level of micromolar concentration (detection limit being 0.82 and 0.35 μM respectively), along with a simple and efficient synthetic procedure. Also the spectral modulation of 2BIMN1O in the presence of the transition metal ions paves the way for the construction of a calibration curve in the context of its fluorescence signaling potential.

Sensor1can detect both copper and fluoride ions selectively in dual sensing mode. Moreover, it has been found to exhibit good membrane permeability for the detection of Cu²⁺in HEK 293 cells.

The present study demonstrates a detailed characterization of the binding interaction of a potential chloride channel blocker 9-methyl anthroate (9-MA) with calf-thymus DNA. The modulated photophysical properties of the emissive molecule within the microheterogeneous bio-assembly have been spectroscopically exploited to monitor the drug–DNA binding interaction. Experimental results based on fluorescence and absorption spectroscopy aided with DNA-melting, viscometric and circular dichroism studies unambiguously establish the binding mode between the drug and DNA to be principally intercalative. Concomitantly, a discernible dependence of the mode of binding between the concerned moieties on the ionic strength of the medium is noteworthy. A dip-and-rise characteristic of the rotational relaxation profile of the drug within the DNA environment has been argued to be originating from a substantial difference in the lifetime as well as amplitude of the free and DNA bound drug molecule. In view of the prospective biological applications of the drug, the issue of facile dissociation of the intercalated drug from the DNA helix via a simple detergent-sequestration technique has also been unveiled. The utility of the present work resides in exploring the potential applicability of the fluorescence properties of 9-MA for studying its interactions with other relevant biological or biomimicking targets.

The present work demonstrates a detailed characterization of the interaction of a potential chloride channel blocker, 9-methyl anthroate (9-MA), with a model transport protein, Bovine Serum Albumin (BSA). The modulated photophysical properties of the emissive drug molecule within the microheterogeneous bio-environment of the protein have been exploited spectroscopically to monitor the probe–protein binding interaction. Apart from evaluating the binding constant, the probable location of the neutral molecule within the protein cavity (subdomain IB) is explored by an AutoDock-based blind docking simulation. The absence of the Red-Edge Effect has been corroborated by the enhanced lifetime of the probe, being substantially greater than the solvent reorientation time. A dip-and-rise characteristic of the rotational relaxation profile of the drug within the protein has been argued to originate from a significant difference in the lifetime as well as amplitude of the free and protein-bound drug molecule. Unfolding of the protein in the presence of the drug molecule has been probed by the decrease of the α-helical content, obtained via circular dichroism (CD) spectroscopy, which is also supported by the gradual loss of the esterase activity of the protein in the presence of the drug molecule.